Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 46.73% vs 80.65% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 43.25% vs 108.32% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 17.16% vs -5.48% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 35.53% vs 112.47% in Mar 2025
Compare Profit and Loss Results of Anlon Healthcare
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
176.00
349.00
-173.00
-49.57%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
176.00
349.00
-173.00
-49.57%
Expenditure (Ex Depriciation)
Stock Adjustments
-16.00
-3.00
-13.00
-433.33%
Raw Materials Consumed
129.00
219.00
-90.00
-41.10%
Power & Fuel Cost
3.00
21.00
-18.00
-85.71%
Employee Cost
5.00
18.00
-13.00
-72.22%
Operating Expenses
3.00
12.00
-9.00
-75.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
15.00
-15.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
2.00
0.00
0.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
130.00
292.00
-162.00
-55.48%
Operating Profit (PBDIT) excl Other Income
46.00
56.00
-10.00
-17.86%
Other Income
0.00
6.00
-6.00
-100.00%
Operating Profit (PBDIT)
46.00
63.00
-17.00
-26.98%
Interest
4.00
0.00
4.00
0%
Profit before Depriciation and Tax
42.00
62.00
-20.00
-32.26%
Depreciation
1.00
4.00
-3.00
-75.00%
Profit Before Taxation & Exceptional Items
40.00
58.00
-18.00
-31.03%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
40.00
58.00
-18.00
-31.03%
Provision for Tax
12.00
14.00
-2.00
-14.29%
Profit After Tax
27.00
43.00
-16.00
-37.21%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
23.00
96.00
-73.00
-76.04%
Profit Available for appropriations
50.00
140.00
-90.00
-64.29%
Appropriations
50.00
140.00
-90.00
-64.29%
Equity Dividend (%)
0%
10%
-10.00
Earnings Per Share
5.84
18.65
-12.81
-68.69%
Profit And Loss - Net Sales
Net Sales 176.50 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 46.73% vs 80.65% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 46.14 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 43.25% vs 108.32% in Mar 2025
Profit And Loss - Interest
Interest 4.35 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 17.16% vs -5.48% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 27.81 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 35.53% vs 112.47% in Mar 2025
Footer loading
